UW Positive Research

04/24/2024

New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.

02/08/2024

What is UWPR CAB? This is our Community Advisory Board, where we meet monthly to exchange ideas, concerns, discuss new studies, plan events and enjoy a meal and get to know each other better. We are in the process of building up and bettering our CAB and we would love for YOU to join and bring your bright ideas!

Sign up here to join our CAB and attend our meetings (in-person or on zoom), every 4th Tuesday of the month: http://tinyurl.com/UWCAB

If you have questions feel free to email us at [email protected]

Our next CAB meeting is February 27th at 5:30, Location TBD. We would be so grateful for you to join!

10/17/2023

Action to eliminate is crucial if we are to progress towards ending because holding stigmatized attitudes towards people with HIV is associated with reduced testing.

https://tinyurl.com/ypt2svw5

10/13/2023

New genetic variant found in those of African ancestry halves viral load.

A genetic variant found by an international team of scientists present only in people of African ancestry seems to halve the set point viral load in people with HIV who are not on treatment. The set point is where viral load stabilises after the early stage of infection, and it determines how fast H...

10/10/2023

Defective particles may drive inflammation despite long-term viral suppression.

People with HIV experience ongoing low-level inflammation which may contribute to worsened health outcomes compared to the general population, however it has been challenging to pin it down on an exact cause.  Findings of a collaboration of scientists from the US National Institutes of Health l...

10/09/2023

‘Dormant’ has ongoing skirmishes with the body’s immune system

In people on HIV drugs, defective viral bits may still exhaust T cells, possibly making it harder to fight back if people go off the drugs.

10/06/2023

Greater weight gain in first year of treatment raises risks of diabetes, metabolic syndrome and precursors of heart disease

https://tinyurl.com/46fc5kpw

10/05/2023

For World AIDS Day 2023, we mark the 35th commemoration of this important day with the theme “Remember and Commit.”

https://tinyurl.com/s42b3wkj

10/04/2023

Our research is being featured in ! Read more here:

Long-acting injectable version of the most popular drug combination is possible.

Researchers at the University of Washington in Seattle say they have cracked the challenge of creating a long-acting injectable form of the world’s most commonly prescribed antiretroviral combination, tenofovir disoproxil fumarate, lamivudine and dolutegravir, often known as TLD. But the drawback ...

10/03/2023

On Thursday, September 21st, 2023, the REPRIEVE Trial hosted a virtual Community Forum to discuss the recently published results of the trial and their meaning for people with HIV.

On Thursday, September 21st, 2023, the REPRIEVE Trial hosted a virtual Community Forum to discuss the recently published results of the trial and their meani...

10/02/2023

A cure for remains elusive, but one word that is commonly heard is “remission.” Even though it doesn’t mean eradication of the virus, remission is a good thing.

But what exactly is remission?

And how does it differ from an ?

https://tinyurl.com/27rmpuaw